- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of infant leukemias: challenge and promise
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2013, Issue 1, Pages 596-600
Publisher
American Society of Hematology
Online
2013-12-06
DOI
10.1182/asheducation-2013.1.596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism
- (2013) Edward Allan R. Sison et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: A Mechanism of Therapeutic Resistance in Pediatric AML
- (2013) E. A. R. Sison et al. MOLECULAR CANCER RESEARCH
- Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
- (2012) T. Bhatla et al. BLOOD
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
- (2012) L Chen et al. LEUKEMIA
- Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements
- (2012) M Nishi et al. LEUKEMIA
- Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia
- (2012) M C Chillón et al. LEUKEMIA
- Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407
- (2012) Wanda L. Salzer et al. PEDIATRIC BLOOD & CANCER
- Genetic variants modify susceptibility to leukemia in infants: A Children's Oncology Group report
- (2012) Julie A. Ross et al. PEDIATRIC BLOOD & CANCER
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study
- (2011) H. Kang et al. BLOOD
- DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
- (2011) A. T. Nguyen et al. BLOOD
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
- (2011) D J P M Stumpel et al. LEUKEMIA
- Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report
- (2011) U Creutzig et al. LEUKEMIA
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting
- (2010) E. Schafer et al. BLOOD
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
- (2010) Christine J. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
- (2010) D J P M Stumpel et al. LEUKEMIA
- Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options
- (2009) D. J. P. M. Stumpel et al. BLOOD
- Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants
- (2009) R. W. Stam et al. BLOOD
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
- (2009) Ching-Hon Pui et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of recurrent or refractory acute lymphoblastic leukemia in infants withMLLgene rearrangements: A report from the Japan infant leukemia study group
- (2009) Daisuke Tomizawa et al. PEDIATRIC BLOOD & CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started